Image-based drug screening combined with molecular profiling identifies signatures and drivers of therapy resistance in pediatric AML Haladik et al. establish high-content imaging and deep-learning-based drug response profiling for pediatric acute myeloid leukemia. Combined with multi-omics profiling, they identify treatment options...

Our paper on high-content drug screening for #PrecisionMedicine in pediatric AML is out!

tinyurl.com/5dbjr7py

I'm extremely grateful to all our co-authors and collaborators!
Special thanks also to the institutions
@cemm.oeaw.ac.at @stanna-ccri.bsky.social @meduniwien.ac.at @fwf-at.bsky.social

20.08.2025 15:24 — 👍 5    🔁 1    💬 0    📌 0

🔬 New @natcomms.nature.com study by CeMM Adjunct PI @floriangrebien.bsky.social's team at CeMM, Vetmeduni Vienna & @stanna-ccri.bsky.social‬ uncovers how NUP98::KDM5A drives #AML via epigenetic rewiring—identifying CDK12 as a druggable target.
➡️ More: bit.ly/3Hm6dVa
➡️ Paper: go.nature.com/3H8eCM3

23.05.2025 06:09 — 👍 5    🔁 3    💬 0    📌 0